Syntec Optics has received over $4 million in new purchase orders from the U.S. life sciences sector, adding to a previous $4.6 million order for laser blood analysis optics. These orders cover a diverse range of biomedical products used in surgical robotics, DNA sequencing, ophthalmology, and veterinary care, highlighting Syntec's critical role in advancing healthcare technology. The company leverages over two decades of expertise in optical manufacturing to support next-generation patient care technologies. This growth reflects Syntec's expanding footprint in life sciences alongside its established presence in defense and space technology markets.
Micron Technology and AI company Anthropic have formed a strategic partnership to enhance next-generation AI infrastructure. The collaboration focuses on designing and supplying advanced memory and storage solutions tailored for AI workloads, includi...
Novo Nordisk has been actively repurchasing its B shares as part of a DKK 15 billion buyback program initiated in February 2026. Since June 15, 2026, the company bought 1.075 million B shares worth approximately DKK 1.78 billion, increasing its treas...
Skyborne Technology, a subsidiary of UAV Corp, has moved critical components of its DART Drone Airship to its Port St. Joe airport for weight balance analysis and flight testing, a crucial step toward FAA Experimental Certification. The testing will ...
Veea Inc. has promoted Greg Deisher to COO, elevated Mark Tubinis to Executive VP, and appointed Thomas Latiolais as CMO to strengthen its leadership amid rapid growth. These moves aim to accelerate commercial growth and expand Veea's AI-powered edge...
Westport Fuel Systems announced a $10 million registered direct offering and a concurrent private placement of common shares and warrants priced at-the-market under Nasdaq rules. The offering includes 4,854,369 common shares or pre-funded warrants an...
